• Laurus Labs’ net profit at Rs 48.8 crore in Q2 FY18 expressbpd
    November 14, 2017
    Hyderabad-based Laurus Labs’ net profit remained flat ₹48.8 crore in Q2 FY18, compared to ₹48.3 crore in Q2 FY17. The total revenue of company grew 4.3 per cent at Rs 538 crore (Rs 516 crore).
  • Pfizer Q2 net dips to Rs 111 cr expressbpd
    November 14, 2017
    Pfizer’s offer for the San Francisco, California-based Medivation goes far beyond the company’s market value of $11.1 billion. Medivation shares closed at $67.16 in Friday trading (Reuters)
  • New study finds no additional benefit from (RS) Meso-Zeaxanthin biospectrumasia
    July 14, 2017
    (RS) Meso-zeaxanthin contributes no additional efficacy to the AREDS2 formulation in subjects with early AMD.
PharmaSources Customer Service